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Summary Three hundred and four suspected cases of malignant melanoma diagnosed in Northern Ireland
over a 5 year period have been reviewed. Two hundred and forty fulfilled the diagnostic criteria of invasive
cutaneous malignant melanoma (CMM) and were accepted as suitable for analysis an incidence of 3.12. The
female to male ratio for CMM in this study is 3:1. This excess of female lesions occurs at all major
anatomical sites and for all tumour types. There are many thick melanomas in the province, and 67% of
cases were greater than 1.7mm thick. Each tumour type has a distinctive age curve. The implications of these
findings are discussed. The evidence suggests that intrinsic factors are as important as extrinsic factors.
Malignant melanoma is a potentially lethal form of
skin cancer. Its incidence and mortality is
increasing in most countries studied. The disease is
found in a younger age group than most other
forms of cancer. Different forms of melanoma may
have different patterns of incidence, growth and
prognosis.
Apart from Scotland (MacKie & Hunter, 1982) it
has been unusual to use the population of an entire
country as the basis for a study of melanoma and
correlate histopathological parameters with age, sex
and site. Northern Ireland is a relatively closed
geographical entity with sufficient numbers of cases
for analysis. Moreover its limited size allows
accessibility to virtually all patients. A detailed'
histopathological examination of all cases of
melanoma referred to the three pathology centres
over a 5-year period was therefore undertaken.
The population of Northern Ireland was
1,538,800 at the time of this study. It is situated
between 54°N and 56°N latitude. There is a
maritime climate and the annual solar radiation
incident on a horizontal surface is 1,000kWh per
square meter (Cruikshank & Wilcock, 1982).
Materials and methods
Data accumulation
One purpose of the study was to identify each new
case of primary cutaneous malignant melanoma
(CMM) which occurred over a given period of
time. This presents a number of difficulties. Cancer
is not a notifiable clinical disease and the Northern
Ireland Cancer Registry contains incomplete
information. For this reason only biopsy proven
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cases were accepted for the study. There are only
three pathology centres in Northern Ireland and all
biopsy specimens are submitted to these centres.
Through the kind co-operation of the consultant
pathologists, the histopathological records of the
three centres were completely reviewed for the 5-
year period between 1974-1978. The only possible
cases of melanoma that might not be included in
this survey would presumably be those cases not
submitted for biopsy. At a joint melanoma group
meeting with general surgeons, plastic surgeons,
pathologists, dermatologists and other clinicians in
the province, it was considered that very few cases
of melanoma would escape histopathological
confirmation in Northern Ireland.
Eye lesions, metastases from primaries diagnosed
previously, and second excisions were all excluded.
Cases of multiple primary melanoma were only
considered if the first primary occurred during the
period of study.
Three hundred and four cases were thus available
for study. Of these, 15 cases of lymph node
melanoma had no identifiable primary site and
were excluded because no cutaneous melanoma has
been found. The remaining 289 cases were
histopathologically examined. Eight cases of anal,
vaginal and nasal mucosal melanoma were excluded
after histopathological examination because no
evidence of involvement of stratified squamous
epithelium was present. Four doubtful cases of
melanoma were excluded following further
histological examination. It is generally agreed that
non-invasive lesions should be considered separately
from invasive malignant melanoma (Hirst, 1977;
Holman et al., 1980) and 37 non-invasive lesions
were therefore excluded. The remaining 240 cases of
CMM formed the basis of this study.
For each case the following additional
information was usually available: name, hospital,
hospital number, sex, age and anatomical site. The
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date of birth for seven patients, and anatomical site
for nine patients were not available. These
unknowns were randomly distributed among the
pathology centres. The following specific
anatomical sites were considered 'normally exposed'
in Northern Ireland: face, neck, scalp, forearm,
hand, lower leg (in females only). The remaining
sites were classified as 'normally unexposed'.
Histopathological assessment
All 240 cases of CMM were reviewed histo-
pathologically by the authors and the consultant
pathologists (see below). Leitz Orthoplan with
fitted ocular micrometer was used to examine all
specimens. When the diagnosis or classification
required additional sections, these were obtained
and examined. To perform multiple cuts on all
specimens was judged impractical and unnecessary
(Sondergaard, 1980). Any parameters not assessable
were denoted as 'impossible to ascertain' and are
not included in the tables.
The criteria used to assign histopathological type
were those given by McGovern et al. (1973) and
Clark et al. (1969, 1975, 1977). Acral-lentiginous
melanoma (ALM) is now recognised as a distinct
entity, and was used in this study as defined by
Arrington et al. (1977). Type was assigned without
reference to clinical information in most cases. For
227 cases tumour type was ascertainable.
Tumour thickness was measured using an ocular
micrometer as described by Breslow (1970). The
earlier classification of depth of invasion by dermal
level suggested by Clark et al. (1969) was also used.
In this paper the classification of measurement
recommended by Day (1981, 1982) was used. For
231 cases a thickness measurement was
ascertainable.
The profile of lesions was classified into three
main groups as they appeared in the fixed histo-
pathological specimen: polypoidal/pedunculated;
flat; or convex/plateau. Lesions with any degree
of histopathological ulceration were assigned the
label 'ulceration present'.
The three major cell groups used were: (i)
epitheloid cells predominant; (ii) spindle cells
predominant; (iii) no predominant cell type.
Statistical analysis
Chi-squared analysis was used to determine
relationships between the different variables. When
numbers were too small for chi-squared analysis,
Fischer's exact probability test was employed. In
the few cases where data could not be ascertained
for a particular variable, such cases were omitted
from chi-squared, exact probability, or age
distribution analysis and are not included in the
tables. All statements of percentage refer to the
percentage of total cases where that variable could
be ascertained. All comments made in Results have
been statistically confirmed.
Age distribution patterns were analysed using the
death rate method, the details of which are given in
the medical tables of the Annual Review of the
Registrar General for England and Wales. All age
group differences mentioned are significant at a
level of P<0.05.
Results
The incidence of cutaneous malignant melanoma in
Northern Ireland is 3.12 per 100,000 population per
year. This compares with a figure of only 2.3
reported by the official Northern Ireland Cancer
Registry for the same period. For one year alone 41
out of 80 cases were missed by the registry.
Of the 240 genuine cases of primary CMM over
the 5 year period, 178 lesions are in females and 62
in males, a ratio of 3:1. The incidence per
100,000 population per year for females is 4.64 and
that for males is 1.63. This female excesss is present
for all major anatomical sites, age groups, and
tumour types.
Sex differences
Age specific incidences for CMM show a general
increase with advancing age in both sexes, but
certain differences are apparent (Figure 1). In the
50-59 age group the most dramatic difference in
age specific incidence between females and males is
seen, viz. a female to male ratio of 6: 1.
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Figure 1 Age specific incidences of CMM (-)
female; (---) male.MELANOMA IN NORTHERN IRELAND 77
Table I General anatomical site distribution of CMM.
Male Female
% of Incidence per % of Incidenceper
male 100,000 population female 100,000population
Site Number CMM per year Number CMM per year
Head/neck 30 49 0.79 45 26 1.17
Trunk 11 18 0.29 31 18 0.81
Hand/arm 7 12 0.18 18 11 0.41
Leg/thigh 7 12 0.18 56 33 1.46
Foot 6 10 0.16 20 12 0.52
Table II Thickness of CMM.
Male Female Total
Thickness
in mm Number % ofmale Number % offemale Number % oftotal
<0.85 5 9 25 16 32 14
18 38 33
0.85-1.69 5 9 39 22 44 19
1.70-3.59 24 41 54 31 78 34
82 62 67
.3.60 24 41 53 31 77 33
The anatomical site distribution also differs
between females and males at a level of statistical
significance (Table I; P<0.001). The absolute
number of female lesions exceeds that for males at
all general anatomical sites. In absolute terms
melanomas of the lower limb are eight times more
common in females. There are also more female
lesions than male for most of the smaller specific
sites even in areas like sole of foot, subungual,
perineal skin and nasal mucosa.
Thick lesions are defined in this study as those
greater than 1.7 mm. There is a significantly greater
proportion of males with thick lesions than females.
(Table II; 0.01 >P>0.001). In males, 86% are
thick under age 60 and 80% are thick at age 60
and over. In females 52% of female lesions are
thick under 60 years and 77% are thick over 60
years.
Tumour type, profile, ulceration, and
predominant cell type do not differ significantly
between females and males. Even inter-relationships
of these variables with age, site and thickness reveal
no sex differences, e.g. thick lesions and thin lesions
show similar percentages ulcerated in males and
females.
Site
Anatomical site distribution is described in Table I.
Table III shows that there are lesions on 'normally
unexposed' sites more than would be expected when
compared to the per cent of surface area occupied
(chi-squared, observed-expected, P<0.001). At the
same time the substantial number of melanomas
developing on unexposed sites is also noted.
Thickness
There is an excess of thick melanomas in the
province (Table II). In this study 67% of assessable
Table III CMM on exposed and unexposed anatomical sites.
Male Female
%of %of %of %of
Exposure Number male surface area Number female surface area
Normally exposed 33 54 18 100 59 30
Normally unexposed 28 46 82 70 41 7078 L.G. GORDON & W.S. LOWRY
cases were > 1.7 mm thick (75% > 1.5 mm). There is
also a significant increase in age specific incidence
of thick lesions with each increasing age group.
Almost invariably the following specific sites also
have all thick lesions: nostril, vulval skin, anal skin,
finger and toe subungual. There is no significant
variation in thickness on normally exposed and
unexposed sites in either sex.
The distribution of thickness by tumour type is
illustrated in Table IV. Even the majority of LMM
are thick in both sexes, 67%. ALM is particularly
thick with 60% of lesions >4.00 mm.
Table IV Thickness distribution by tumour type.
<1.7mm .1.7mm
Tumour
type % of % of
Number each type Number each type
NM 21 22 75 78
SSM 35 56 27 44
ALM 5 20 20 80
LMM 14 33 29 67
Type
Forty-two per cent of all lesions with known type
in this study are classified as NM, 27% as SSM,
20% LMM, and 11% ALM. There are significant
variations in age-specific incidence patterns for each
tumour type (see Table V).
Table V Tumour type by age group for CMM (age
specific incidences in brackets).
Tumour type
Age
group NM SSM ALM LMM
20 4 (0.14) 0 (0) 0 (0) 0 (0)
20-29 8 (0.72) 4 (0.36) 0 (0) 0 (0)
30-49 30 (1.74) 25 (1.45) 2 (0.12) 3 (0.17)
50-69 28 (1.96) 24 (1.68) 15 (1.05) 15 (1.05)
70+ 24 (4.32) 7 (1.26) 8 (1.44) 24 (4.32)
Profile
The most common tumour profile is convex/plateau
accounting for 44% of those assessable; 41% of
lesions are polypoidal/pedunculated; 15% are flat.
Tumour profile is not related to tumour type
(0.1 >P> 0.05). Polypoidal/pedunculated lesions
tend to be thicker than other profiles (P<0.001).
All male polypoidal lesions and 92% of all female
polypoidal lesions are thicker than 1.7mm.
Ulceration
Fifty-eight per cent of all lesions in this study are
ulcerated. Not surprisingly there is more tendency
to ulceration in thicker lesions (P=0.000). More
polypoidal/pedunculated lesions are ulcerated than
any other tumour type (P<0.001).
Cell type
Tumours with predominantly epitheloid cell type
represent 39% of tumours, 36% of lesions contain
no predominant cell type and in 25% spindle cells
are predominant. Fifty-five per cent of spindle cell
lesions are on the head and neck, 18% on the foot
and 18% on the trunk. Forty per cent of epitheloid
lesions are on the leg. Spindle cell melanomas tend
to be deeper than other cell types with 86% of
lesions thick (P=0.001). Spindle cell lesions also
tend to be more ulcerated than other cell types
(P=0.041).
Discussion
At present cancer is not a notifiable disease in
Northern Ireland and the official cancer registry
contains incomplete information. Inaccuracies in
the registry had already been noted in previous
studies of gynaecological cancer in Northern
Ireland (Lowry & Lynch, 1981). In the present
study discrepancies of over 50% were noted in the
registry when the pathology reports were compared
with clinical notification. The reasons for these
errors are complex and beyond the scope of this
paper. However the problems associated with
cancer registration are not unique to Northern
Ireland and have been found in other studies
elsewhere. The present study highlights the
importance of obtaining biopsy proven cases for an
investigation of this kind. In this connection it is of
interest that Australia has recently made cancer a
notifiable disease and that the responsibility for
notification lies with the pathologist not the
clinician in that country.
Possible melanomas not included in this study
would therefore be those cases not submitted for
biopsy. Such possibilities include cases which were
so early they appeared clinically benign at the time
of excision, moribund patients with such advanced
disease that intervention was considered in-
appropriate, and patients who refused to consult
their doctor or who declined investigation when
confronted with the possible diagnosis. Such cases
will almost always be missed in any study but the
melanoma group considered there would be
relatively few instances in this series.
The incidence of 3.12/100,000 is similar to a few
other population based studies during the same
time period, but is lower than for instance NorwayMELANOMA IN NORTHERN IRELAND 79
(Magnus, 1981), and extremely low compared with
Australia (Holman et al., 1980).
The three-to-one female to male ratio in
Northern Ireland is one of the highest so far
reported and suggests that hormonal or other sex-
related environmental or genetic factors may be
particularly important in this population. In the
British Isles a female to male ratio for melanoma of
approximately two-to-one has been reported (Lee &
Storer, 1980; MacKie & Hunter, 1982) compared
with only a small female excess in most other parts
of the world. It may be that this marked sex
differential is obliterated in other countries by a
larger number of predominantly 'solar' cases in
those areas.
The high preponderance of female melanoma in
Northern Ireland is found for all major anatomical
sites, not only the lower limb. It even exists in head
and neck disease and for LMM where, because of
occupational ultraviolet exposure one might
anticipate a high incidence in males. The age
distribution in females also suggests that hormonal
mechanisms may be important. There is a steady
increase in incidence during ages of high oestrogen
activity and a levelling off around the time of the
menopause. It is at this time, when hormonal
changes are at their most profound, that the most
dramatic difference between female and male
incidence is seen.
Male lesions tend to be thicker than female
lesions. This feature reflects tumour progression
once the disease is established rather than variation
in initial susceptibility to the disease. Thickness
differences could be due to longer diagnostic delay
in males. Alternatively females may be more
susceptible to initiating factors whereas males may
have weaker defence mechanisms once the disease is
established. Although solar radiation may be an
initiating factor in some melanomas, it is unlikely
to be responsible for the sex differences in tumour
progression as there are no thickness differences
between exposed and unexposed sites in males and
females. The suggestion that hormonal factors
might influence the development of melanoma is
also supported by the embryological derivation of
the melanocyte from the neural crest. Hormonal
influence on tumour growth is supported by the age
distribution of thick lesions in men and women.
Females develop thicker lesions after the meno-
pause. On the other hand as males grow older
lesions have less tendency to become thick.
This study confirms that ultraviolet radiation is a
major factor in the aetiology of many melanomas.
The high incidence of CMM on the head and neck
supports this view as does the high incidence on the
female lower leg and other 'normally exposed' sites.
However, the relatively high incidence of melanoma
on the foot (11% of total) and on other unexposed
sites suggests some additional unknown aetiological
factors apart from ultraviolet radiation. The
distribution and variation of melanoma may
therefore depend on both extrinsic and intrinsic
factors. The instrinsic factors could possibly include
embryological derivation, distribution of naevi,
density ofmelanocytes and other factors.
There is a higher proportion of thick lesions in
Northern Ireland than in most other studies, e.g.
Shaw et al., 1980; Balch et al., 1978; MacKie &
Hunter, 1982; Eastwood & Baker, 1983. This could
be due to more aggressive disease but is more likely
related to diagnostic delay associated with
decreased public and professional awareness of the
disease.
LMM, SSM and ALM each have distinct
patterns of distribution which suggest that different
initiation events and different primary cell types
may be involved in each tumour type leading to
different patterns of growth. The link between
LMM and ultraviolet radiation is well recognised
and is similar to that described for squamous and
basal cell carcinomas (McGovern et al., 1980; Clark
& Mihm, 1969). The age and site distribution of
LMM in Northern Ireland supports a cumulative
dose ultraviolet aetiology. Although LMM is
different in some respects to other types of
melanoma it also invades deeply in most cases in
Northern Ireland.
ALM also has a lentiginous growth. It differs
from LMM however in age distribution, site, and
depth of penetration. ALM lesions are particularly
thick and it may be that the obscure anatomical
sites delay its discovery. LMM lesions are probably
precipitated by ultraviolet radiation but the obscure
site distribution of ALM suggests some other factor
is involved. The variation in age distribution
between ALM and LMM also supports this with
ALM showing significant increase in age-specific
incidence only in the middle-age range.
SSM tends to be less advanced than other forms
of melanoma. Although a cohort effect cannot be
excluded, the age distribution suggests that this
lesion could be related to a single initiating event,
or the coincidence of more than one event at a
single point in time. The pattern of NM in this
study is not distinctive. It may be that NM is often
an end-stage lesion that began as another type
which has been obliterated by the nodular growth
phase.
Tumour profile gives additional information on
melanoma independent of tumour type. The
increased thickness of polypoidal/pedunculated
lesions may represent less restrictions on physical
growth as they grow outwardly. It may also
indicate more aggressive disease.80 L.G. GORDON & W.S. LOWRY
The presence of spindle cell lesions on both
exposed and unexposed sites suggests that cell type
is determined not by the aetiological agent but by
the intrinsic nature of the melanocyte itself. The
same initial cell may progress in one direction
(LMM) in one set of circumstances and in another
direction (ALM) in another set ofcircumstances.
Ultraviolet radiation is known to be an
important aetiological factor in melanoma and this
is confirmed in the present study. But this is clearly
not the only factor, or indeed the major factor, in
the substantial number of cases which occur on
unexposed sites. The high proportion of female
patients in Northern Ireland and the excess of
females at all sites and ages suggest that hormonal
factors are also important. The evidence suggests
therefore that intrinsic factors may be at least as
important as extrinsic factors in the pathogenesis of
some forms of melanoma in Northern Ireland. The
high proportion of thick lesions in this study
suggests delay factors and is a cause for concern.
The hope is that one may eventually be able to
identify patients at high risk and at the same time
increase public and professional awareness of this
disease.
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